undamentalytics Newsletter

Kazia Therapeutics LTD valuation and forecast

Explore the models for Kazia Therapeutics LTD, adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

9 analysts, Nov 2026
Buy9100%
Hold00%
Sell00%

Monthly trend

  1. Nov 2026369
  2. Oct 2026246
  3. Sep 2026246

Counts of recommendations published by analysts covering Kazia Therapeutics LTD, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

KZIA valuation questions

How does Fundamentalytics value Kazia Therapeutics LTD?
We use the models that fit Kazia Therapeutics LTD's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Kazia Therapeutics LTD.

Compare with peers